ResMed Announces Participation in the 41st Annual J.P. Morgan Healthcare Conference
ResMed (NYSE: RMD) announced that CEO Mick Farrell will present at the 41st Annual J.P. Morgan Healthcare Conference on January 9, 2023, at 1:30 p.m. PST in San Francisco. The company is known for its innovative solutions aimed at treating chronic diseases like sleep apnea and COPD, enhancing patients' quality of life through digital health technologies. Investors can access the live audio-only webcast and a replay will be available post-event for 30 days. ResMed operates in over 140 countries, focusing on out-of-hospital support systems.
- Mick Farrell will present at a major healthcare conference, potentially enhancing company visibility.
- ResMed's innovative solutions address chronic disease management, supporting long-term growth.
- Presence in over 140 countries indicates a strong global market position.
- None.
SAN DIEGO, Jan. 02, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will present at the 41st Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2023, beginning at approximately 1:30 p.m. (Pacific Standard Time) at the Westin St. Francis in San Francisco, CA.
More information about this event, including access to the live, audio-only webcast, may be accessed by visiting https://investor.resmed.com. The audio-only webcast replay will be available approximately 24 hours after the live webcast ends and will be accessible for the following thirty (30) days.
About ResMed
At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries. To learn more, visit ResMed.com and follow @ResMed.
| For investors | For media |
| Amy Wakeham | Jayme Rubenstein |
| +1 858.836.5000 | +1 858.836.6798 |
| investorrelations@resmed.com | news@resmed.com |
FAQ
When will RMD present at the J.P. Morgan Healthcare Conference?
Where is the J.P. Morgan Healthcare Conference taking place?
How can I access the live webcast of the ResMed presentation?
What technologies does ResMed focus on?
In how many countries does ResMed operate?
